drugset / Trial / NCT02612857
Trial of IMO-8400 in Adult Patients With Dermatomyositis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine how safe and effective IMO-8400 is in adults with dermatomyositis.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-05-16
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAZLITORAN | Oligonucleotide (other) | — | Subcutaneous |